Neurocrine Biosciences, (NBIX) Institutional Ownership
Track institutional investors, ownership changes, and 13F filings.
Ownership Summary
Total Institutions
607
Total Shares Held
94.36M
Total Value
$12.87B
Institutional Holding %
93.98%
Ownership Distribution
Top 5 Holders
Top Institutional Holders (as of Dec 31, 2024)
| Institution | Shares | Ownership % | Value |
|---|---|---|---|
| BlackRock | 14.78M | 14.72% | $2.02B |
| VANGUARD | 10.12M | 10.08% | $1.38B |
| STATE STREET | 4.89M | 4.84% | $667.65M |
| DODGEX | 3.02M | 3.00% | $411.74M |
| CITADEL | 2.54M | 2.53% | $346.45M |
| RENAISSANCE TECHNOLOGIES | 2.49M | 2.48% | $339.80M |
| AQR | 1.90M | 1.88% | $258.93M |
| GEODE | 1.88M | 1.87% | $255.52M |
| BELLEVUE | 1.82M | 1.81% | $248.43M |
| MORGAN STANLEY | 1.57M | 1.57% | $214.76M |
Recent Insider Trading
| Insider | Title | Transaction | Shares | Value | Date |
|---|---|---|---|---|---|
| Cooke Julie | Chief Human Resources Officer | A-Award | 29.60K | $3.47M | Feb 12, 2025 |
| Cooke Julie | Chief Human Resources Officer | M-Exempt | 1.40K | $- | Feb 13, 2025 |
| Cooke Julie | Chief Human Resources Officer | M-Exempt | 1.51K | $- | Feb 13, 2025 |
| Cooke Julie | Chief Human Resources Officer | S-Sale | 755 | $88.18K | Feb 13, 2025 |
| Cooke Julie | Chief Human Resources Officer | S-Sale | 796 | $92.95K | Feb 13, 2025 |
| Cooke Julie | Chief Human Resources Officer | A-Award | 5.55K | $- | Feb 12, 2025 |
| Cooke Julie | Chief Human Resources Officer | M-Exempt | 1.40K | $- | Feb 13, 2025 |
| Cooke Julie | Chief Human Resources Officer | M-Exempt | 1.51K | $- | Feb 13, 2025 |
| Gorman Kevin Charles | Director | M-Exempt | 5.60K | $- | Feb 13, 2025 |
| Gorman Kevin Charles | Director | M-Exempt | 5.38K | $- | Feb 13, 2025 |
Recent Position Changes
| Institution | Shares Changed | % Change | Date |
|---|---|---|---|
| DODGEX | +1.73M | +134.23% | Feb 13, 2025 |
| RAYMOND JAMES FINANCIAL | +843.90K | +100.00% | Apr 23, 2025 |
| CITADEL | +773.52K | +43.84% | Feb 14, 2025 |
| WELLINGTON LLP | +739.20K | +102.92% | Feb 12, 2025 |
| THRIVENT FINANCIAL FOR LUTHERANS | +711.97K | +2759.36% | Feb 10, 2025 |
| ARMISTICE | +710.62K | +391.78% | Feb 14, 2025 |
| ORBIMED | +635.90K | +210.41% | Feb 14, 2025 |
| BlackRock | +526.67K | +3.69% | Feb 07, 2025 |
| JENNISON | +485.89K | +145.13% | Jan 24, 2025 |
| DEERFIELD COMPANY (SERIES C) | -454.59K | -34.53% | Feb 14, 2025 |
Recent Ownership Filings
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 14, 2025
4
Form 4 - Statement of changes in beneficial ownership of securities
Feb 14, 2025
144
Form 144 - Report of proposed sale of securities
Feb 14, 2025
144
Form 144 - Report of proposed sale of securities
Feb 13, 2025
144
Form 144 - Report of proposed sale of securities
Feb 13, 2025
144
Form 144 - Report of proposed sale of securities
Feb 13, 2025
144
Form 144 - Report of proposed sale of securities
Feb 13, 2025
144
Form 144 - Report of proposed sale of securities
Feb 13, 2025
144
Form 144 - Report of proposed sale of securities
Feb 13, 2025
144
Form 144 - Report of proposed sale of securities
Feb 13, 2025
144
Form 144 - Report of proposed sale of securities
Feb 13, 2025
Related Metrics
Explore detailed financial metrics and analysis for NBIX.